240 words...one minute read

Currently, many places across the globe are experiencing a surge in pediatric cases of RSV, influenza and COVID-19, causing a shortage in over-the-counter fever reducers and amoxicillin. Globally, the COVID-19 positivity rate has increased to over 10 percent after a long-term downward trend beginning in mid-2022. Some pharmacies recently imposed purchase limits on children’s cold and flu medicines, and the Center for Disease Control Prevention in the United States is encouraging people to wear masks to help reduce the spread of all three illnesses.

What have we learned from the past two years of the COVID-19 pandemic that can apply today?

• The global outbreak of COVID-19 created challenges around the world. During catastrophic events, all parts of an organization can be impacted. Explore Aon’s COVID-19 insights, which help business leaders implement effective responses to the impact the pandemic will continue to have on businesses, employees and communities.
• The COVID-19 pandemic has also affected supply chains. Aon’s whitepaper, “Supply Chains – Turning risks into opportunities,” explores how supply chain vulnerabilities were exposed during the COVID-19 pandemic – and how to mitigate those issues.
• This year, the World Health Organization declared the monkeypox outbreak a national health emergency. Read more to learn how Aon helped clients implement effective responses to the early impacts of COVID-19, which can be applied to public health issues globally.